Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteomic patterns for early cancer detection.

Timothy D Veenstra1, Darue A Prieto, Thomas P Conrads

  • 1Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick Inc., National Cancer Institute at Frederick, Frederick, MD 21702-1201, USA. veenstra@ncifcrf.gov <veenstra@ncifcrf.gov>

Drug Discovery Today
|October 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ATR kinase inhibitors induce mitochondrial fission in CD8<sup>+</sup> T cells and impair immune memory <i>in vivo</i>.

bioRxiv : the preprint server for biology·2026
Same author

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Nature communications·2026
Same author

Laser capture microdissection.

Nature reviews. Methods primers·2026
Same author

Immunoproteomic insights into inflammatory diseases of the critically endangered black rhinoceros (Diceros bicornis).

Scientific reports·2026
Same author

Longitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor Surveillance.

Cells·2026
Same author

Progestin and vitamin D synergistically inhibit fallopian tube carcinogenesis.

Gynecologic oncology·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026
Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026
Same journal

A20 as a novel immunoregulatory target for neuroinflammation.

Drug discovery today·2026
See all related articles

Proteomic pattern analysis offers a revolutionary approach for early disease diagnosis, identifying novel biomarkers for conditions like ovarian, breast, and prostate cancer. This sensitive technology aids in early detection and predicting therapy response.

Area of Science:

  • Biomarker Discovery
  • Proteomics
  • Cancer Diagnostics

Background:

  • Proteomics aims to discover novel biomarkers for disease diagnosis, susceptibility prediction, and progression monitoring.
  • Mass spectral identification of proteins in complex biosystems like serum and tissues is a key focus.
  • Early disease diagnosis is crucial for effective treatment and patient outcomes.

Purpose of the Study:

  • To introduce a revolutionary approach in proteomic pattern analysis for early disease diagnosis.
  • To highlight the potential of this technology as a sensitive diagnostic tool.
  • To explore its utility in predicting response to therapy.

Main Methods:

  • Proteomic pattern analysis of clinical samples.
  • High-throughput analysis of hundreds of samples per day.

Related Experiment Videos

  • Mass spectral identification techniques.

    • Main Results:

    • Demonstrated effectiveness in the early diagnosis of ovarian, breast, and prostate cancer.
    • High sensitivity as a diagnostic tool.
    • Potential for predicting therapeutic response.

    Conclusions:

    • Proteomic pattern analysis is a powerful tool for early disease detection.
    • This technology can serve as a novel biomarker discovery platform.
    • It holds significant promise for personalized medicine and improved patient care.